Nathan Archer

Asst. Prof. of Dermatology @HopkinsMedicine. We study immune responses during skin infections and inflammatory diseases to develop novel immunotherapies

[Hopkins Med News @HopkinsMedNews]

Lung inflammation in patients with #eczema may be caused by a tissue-specific immune response to S. aureus, a common skin microbe. The recent @CellReports study led by @ArcherLab and @HopkinsMedicine researchers links eczema, S. aureus, and asthma. https://t.co/Qx2NAGQ2PG.

[Nathan Archer @ArcherLab]

Want to learn more about #biofilms and how they evade #antimicrobial killing or host #immunity? Please join us for the 3rd Shirtliff Biofilm Symposium on June 13th in Philly! Sign up below.

https://t.co/HpcWsVJOTA

[Nathan Archer @ArcherLab]

Shout to @Jen_M_Wu and Laine Feller for representing @ArcherLab at the Gram+ Pathogens meeting. Both gave excellent talks on host responses to S. aureus #skin #infections and #inflammation. #ProudPI @HopkinsMedicine #dermatology

[Nathan Archer @ArcherLab]

@DongXintong @LEOFondet Thank you Xintong!

[Nathan Archer @ArcherLab]

I am excited to share that we received a Serendipity Grant from the @LEOFondet to study the role of adipocytes in #skin #inflammation. This is important, as obesity is linked to increased susceptibility of developing atopic dermatitis and psoriasis.

https://t.co/G8JbJs02HJ

[Nathan Archer @ArcherLab]

@HobbsDermLab @LEOFondet Thank you Ryan!

[Nathan Archer @ArcherLab]

@TaniaWong88 @LEOFondet Thank you Tania!

[Nathan Archer @ArcherLab]

@McLoughlin_Lab @LEOFondet Thank you Rachel!

[Nathan Archer @ArcherLab]

@KielianLab Thank you Tammy!

[Frontiers - Infectious Disease @FrontInfectDis]

🔔Extended Submission Deadline!🔔

Due to popular demand, the Research Topic: "From Bench to Clinic: Novel Vaccines and Therapeutics – “Success Stories” is extended!

Edited by: Prof. Nathan K. Archer, and Dr. Aru Venkatasubramaniam

NEW Deadline: 27th Sept 2024
👉Get involved: https://t.co/S9AfL3VtQw

[Tammy Kielian @KielianLab]

Excited to share this publication by my MD/PhD student @ZachVanRoy on the complex roles of TNF during S. aureus craniotomy infection. https://t.co/tZUjG9pT1r @UNMC_mdphd @UNMC_PathMicro #ProudPI

[Dr Rachel Mcloughlin @McLoughlin_Lab]

Very proud of this latest work from the lab! As we suspected, the immune imprint from a lifetimes exposure to S. aureus might be the reason vaccine have continually failed to drive protective immunity.

[Tammy Kielian @KielianLab]

Thankful for our ongoing collaboration with Drs. Kevin Garvin and Curtis Hartman to examine immune responses in patients with prosthetic joint infection in @jclinicalinvest . Study led by @aru_prabhakar and Chris Horn #biofilm
https://t.co/dYOyKGKVzk

[Alex Weber, immunologist researcher in Tübingen @Innate_immuno]

Our most recent work on naRNA, a novel #Neutrophil extracellular trap (NET) component propagating #inflammation via NLRP3 #inflammasome is now out at #EMBO Reports 👉 https://t.co/wTiHyuD7hT

[Nathan Archer @ArcherLab]

Want to learn more about how S. aureus proteases promote skin #inflammation? Check out this review by @sabostars @JennySaito12 from @HopkinsMedicine.
#dermtwitter

https://t.co/c29YaLsowZ

[Tammy Kielian @KielianLab]

Excited to share this preprint describing a bacterial single-cell RNA-seq platform to interrogate biofilm heterogeneity and transcriptional adaptations following immune cell exposure. Great work by @LKorshoj! #Biofilm @UNMC_PathMicro
https://t.co/NurAlAzOxM

[Nathan Archer @ArcherLab]

@DaneParkerLab @Rutgers_NJMS Congrats Dane!!!

[Cell Host & Microbe @cellhostmicrobe]

Host stress drives tolerance & persistence: The bane of anti-microbial therapeutics
@SophieHelaine @theconlonlab @DavisLabJHU & Russell @cornellvet discuss pathways that promote antibiotic recalcitrance of M.tuberculosis, S.aureus, S.enterica & Yersiniae https://t.co/CgDrre5Gs6

[Nathan Archer @ArcherLab]

@DavisLabJHU @WeiserLabNYU @IsbergRalph @andrewpekosz @sabraklein1998 Congrats Kim!!! Excellent news!

[Nathan Archer @ArcherLab]

Congrats to Yu Wang @HopkinsMedicine and @IBT_inc on study to develop dry formulations of the #Saureus #vaccine IBT-V02, which were effective against strains from around the world and may have utility in countries where cold storage is scarce. 👇
https://t.co/yML2ShcUZ4